An important PR to understanding one of the many long term and exceptionally "close knit" relationships between iBIO and Texas A&M regarding the latest Fed funding to Fuji, for ramping up production of a NVAX's CV19 vaccine on College Station which is known as the A&M BioCorridor. iBio is heavily involved w/ Texas A&M:
Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals
Facilities like iBio were built with disease treatment in mind:
"It's serious here as we're looking at the situation unfolding. And we're monitoring it very, very closely because in particular this facility here at iBio was specifically designed both the production capacity as well as the technology to respond rapidly to really any pandemic sort of outbreak," said Tom Isett, iBio Board of Directors Member.